TY - JOUR
T1 - Evidence of the impacts of pharmaceuticals on aquatic animal behaviour
T2 - a systematic map protocol
AU - Martin, Jake M.
AU - Bertram, Michael G.
AU - Blanchfield, Paul J.
AU - Brand, Jack A.
AU - Brodin, Tomas
AU - Brooks, Bryan W.
AU - Cerveny, Daniel
AU - Lagisz, Malgorzata
AU - Ligocki, Isaac Y.
AU - Michelangeli, Marcus
AU - Nakagawa, Shinichi
AU - Orford, Jack T.
AU - Sundin, Josefin
AU - Tan, Hung
AU - Wong, Bob B.M.
AU - McCallum, Erin S.
N1 - Funding Information:
This project was developed from discussions amongst the session leaders and panellists at the behavioural ecotoxicology session at the Society for Environmental Toxicology and Chemistry (SETAC) North America 40th Annual General Meeting in Toronto, Canada.
Funding Information:
Open access funding provided by Swedish University of Agricultural Sciences. This project was supported by funding from the Swedish Research Council Formas to ESM (Dnr. 2020-00981), the Swedish Research Council Formas to TB (Dnr. 2018-00828), and funding from the Australian Research Council (DP190100642 and FT190100014) to BBMW.
Publisher Copyright:
© 2021, The Author(s).
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/10/18
Y1 - 2021/10/18
N2 - Background: Globally, there is growing concern over the impacts of pharmaceuticals and drug manufacturing on aquatic animals, and pharmaceuticals are now recognized as contaminants of emerging environmental concern. In recent years, scientists, environmental managers, and policymakers have been interested in using behavioural endpoints for chemical regulation, given their importance for fitness and survival. The body of research on whether and how pharmaceutical exposure alters the behaviour of aquatic animals has grown exponentially, making it difficult to get an overview of the results. With an international spotlight on the management of these environmental threats, synthesizing the currently available data is vital to inform managers and policymakers, as well as highlighting areas where more research is needed. This is a protocol for a systematic evidence map (SEM) and serves as an a priori record of our objectives and methodological decisions. Our objectives are to identify, catalogue, and present primary research articles on the effects of human and veterinary pharmaceuticals on aquatic animal behaviour. Methods: The literature search will be conducted using two electronic databases: Web of Science and Scopus, and we will supplement these searches with additional sources. The search string has been developed using a Population–Exposure–Comparison–Outcome (PECO) framework, to capture articles that used an aquatic organism (P, population) to test the effects of a pharmaceutical (E, exposure) on behaviour (O, outcome). Eligible articles must also have a control group (C, comparison). Articles will be screened in two stages, title and abstract, followed by full-text screening before data extraction. Decision trees have been designed a priori to appraise articles for eligibility at both stages of screening. At both stages, screening each article will be completed by two independent reviewers. Study validity will be appraised but not used as a basis for article inclusion. The information extracted from the eligible articles, along with bibliometric data, will be mapped and displayed. All data associated with this SEM will be publicly available through the Open Science Framework (OSF) and a future project webpage.
AB - Background: Globally, there is growing concern over the impacts of pharmaceuticals and drug manufacturing on aquatic animals, and pharmaceuticals are now recognized as contaminants of emerging environmental concern. In recent years, scientists, environmental managers, and policymakers have been interested in using behavioural endpoints for chemical regulation, given their importance for fitness and survival. The body of research on whether and how pharmaceutical exposure alters the behaviour of aquatic animals has grown exponentially, making it difficult to get an overview of the results. With an international spotlight on the management of these environmental threats, synthesizing the currently available data is vital to inform managers and policymakers, as well as highlighting areas where more research is needed. This is a protocol for a systematic evidence map (SEM) and serves as an a priori record of our objectives and methodological decisions. Our objectives are to identify, catalogue, and present primary research articles on the effects of human and veterinary pharmaceuticals on aquatic animal behaviour. Methods: The literature search will be conducted using two electronic databases: Web of Science and Scopus, and we will supplement these searches with additional sources. The search string has been developed using a Population–Exposure–Comparison–Outcome (PECO) framework, to capture articles that used an aquatic organism (P, population) to test the effects of a pharmaceutical (E, exposure) on behaviour (O, outcome). Eligible articles must also have a control group (C, comparison). Articles will be screened in two stages, title and abstract, followed by full-text screening before data extraction. Decision trees have been designed a priori to appraise articles for eligibility at both stages of screening. At both stages, screening each article will be completed by two independent reviewers. Study validity will be appraised but not used as a basis for article inclusion. The information extracted from the eligible articles, along with bibliometric data, will be mapped and displayed. All data associated with this SEM will be publicly available through the Open Science Framework (OSF) and a future project webpage.
KW - Ecotoxicology
KW - Evidence synthesis
KW - Fitness
KW - Medicine
KW - Neurotoxicology
KW - Psychoactive
UR - http://www.scopus.com/inward/record.url?scp=85117481870&partnerID=8YFLogxK
U2 - 10.1186/s13750-021-00241-z
DO - 10.1186/s13750-021-00241-z
M3 - Article
AN - SCOPUS:85117481870
SN - 2047-2382
VL - 10
JO - Environmental Evidence
JF - Environmental Evidence
IS - 1
M1 - 26
ER -